Head and Neck Cancer Trial, Recruiting NCT07293013 Sponsor: Chiayi Christian Hospital Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07293013
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 20 years of age or older
  • People who have been diagnosed with a primary (original, not returned) cancer located in the head and neck area, and who are preparing to receive radiation therapy or a combination of radiation and chemotherapy together
  • People whose total planned radiation dose falls between 6000 and 7200 cGy (a unit used to measure radiation)
  • People who are awake, alert, and able to communicate in Mandarin or Taiwanese
  • People who are willing to take part after having the study explained to them, and who are able to sign a consent form

Who may not be able to join:

  • People whose head and neck cancer has come back and who are going through a second round of radiation therapy or combined radiation and chemotherapy
  • People who have a known allergy or history of allergy to any ingredient in the treatment being tested in this trial
  • People who are unable to open their mouth because of a skin graft
  • People whose cancer is known to have spread to other parts of the body (referred to medically as M1 or distant metastasis)
  • People who have already developed mouth sores (a condition called oral mucositis) before the trial begins
  • People who have skin diseases, autoimmune conditions, or who a doctor has determined are not suitable for this study for other reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-5-2765041 Ext. 2600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chiayi Christian Hospital
Registry
ClinicalTrials.gov
Start date
4 December 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Assessment severity of OM

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov